the pharmaletter | chinese answer to alzheimer's puzzle?-ayx爱游戏官网登录

features
the pharmaletter | chinese answer to alzheimer's puzzle?
date:2018-10-30

evidence of an effective new treatment for alzheimer’s would create shock waves across healthcare given the extent of the global need among millions of patients.

but it could also be a major event in geopolitics, given what making progress in this highly complex disease would say about a country’s scientific capabilities.

so it is potentially significant that a chinese company, green valley pharmaceutical, has achieved the rare feat of getting a positive read-out in a phase iii trial in mild-to-moderate alzheimer's disease.

"gv-971 could help diversify the portfolio of treatments for this terrible disease"

full story here: 


shareto:
previous page:
alzforum | fits and starts: trial results from the ctad conference
next page:
medscape news | positive topline results for novel alzheimer's drug
网站地图